ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction

American Family Physician

Volumn 79, Issue 12, 2009, Pages 1080-1086

  Campbell Scherer, Denise L ^a   Green, Lee A ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; NARCOTIC ANALGESIC AGENT; PARACETAMOL; TRAMADOL;

BLOOD PRESSURE REGULATION; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; DEATH; FIBRINOLYTIC THERAPY; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; LIPID DIET; LONG TERM CARE; LOW DRUG DOSE; MAINTENANCE THERAPY; MEDICAL SOCIETY; MORTALITY; MUSCULOSKELETAL PAIN; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; RECURRENT DISEASE; REPERFUSION; REVIEW; SECONDARY PREVENTION; SMOKING CESSATION; ST SEGMENT ELEVATION;

EID: 67649259143     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) [published corrections appear in Circulation. 2005;111(15):2013-2014, and Circulation. 2007;115(15):e411]. Circulation. 2004;110(9):e82-e292.
2. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008;117(2):296-329. http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.107. 188209. Accessed March 9, 2009.
3. National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). http://hp2010.nhlbihin.net/atpiii/calculator. asp?usertype=prof. Accessed March 9, 2009.
4. Chen ZM, Pan HC, Chen YP, et al., for the COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366(9497):1622- 1632.
5. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104(13):1577-1579.